Solidarity PLUS trial for promising drugs will roll out in 52 countries, an unprecedented global collaboration for COVID-19 R&D The World Health Organization (WHO) has announced the next phase in its Solidarity trial: Solidarity PLUS will enroll hospitalized...
A multinational, multi-site team of researchers led by Peter Jüni of St. Michael’s Hospital and the University of Toronto in Canada investigated the efficacy of heparin as a treatment for moderate to severe SARS-CoV-2 infection, the virus behind the COVID-19 pandemic....
Combining tocilizumab and sarilumab along with corticosteroids reduced the risk of death by 17% compared with corticosteroids alone. CIDRAP: WHO Advises 2 Monoclonal Antibodies For Severe COVID The World Health Organization (WHO) today recommended the use of...
TrialSite has emphasized the importance of research in the fight against COVID-19 and many other infectious diseases and other threats to humanity. Recently, researchers from the Tokyo University of Science (along with scientists from the National Institute of...
June 13, 2021 ~ TrialSite News Japanese-Led Team’s Preclinical Research Indicate Huge Potential for the Repurposed Drug Combo of Cepharanthine/Nelfinavir to Destroy COVID-19 A team of researchers from Japan, America, and the United Kingdom recently launched a study to...
June 1, 2021 ~ Trial Site News Indian Giant Reliance Industries Developing Niclosamide-based Drug Targeting COVID-19 Much like Ivermectin, Niclosamide is in the anthelmintic family of drugs, and recently, Indian mega-corporation Reliance Industries Ltd....
https://www.sciencedaily.com/releases/2021/04/210402162939.htm Originally published by: ScienceDaily Author: UPenn School of Medicine Date: 4/2/2021 Categories: Integrative Therapies,Treatment,Repurposed Drugs,Cyclosporine,Dacomitinib,Salinomycin
https://www.medpagetoday.com/infectiousdisease/covid19/91788?xid=nl_covidupdate_2021-03-25&eun=g1435132d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=DailyUpdate_032521&utm_term=NL_Gen_Int_Daily_News_Update_active Originally published by: Med Page Today...
https://scitechdaily.com/promising-at-home-Integrative Therapies,Treatment-for-covid-19-discovered-fda-approved-drug-for-leprosy/ Originally published by: Scitechdaily Author: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Date: 3/16/2021 Categories: Integrative...
Promising At-Home Treatment for COVID-19 Discovered: FDA Approved Drug for Leprosy From SciTechDaily Phase 2 clinical trial could begin immediately for clofazimine, an FDA-approved drug on WHO’s List of Essential Medicines. A Nature study authored by scientists at...
https://www.cbsnews.com/news/fluvoxamine-antidepressant-drug-covid-Integrative Therapies,Treatment-60-minutes-2021-03-07/ Originally published by: CBS 60 Minutes Author: Sharyn Alfonsi Date: 3/7/2021 Categories: Prevention,Repurposed Drugs,Fluvoxamine
https://endpts.com/covid-19-roundup-recovery-trial-halts-recruitment-for-colchicine-study-after-finding-no-convincing-evidence-italy-blocks-astrazeneca-vaccine-shipment-meant-for-australia/ Originally published by: Endpointsnews Author: Max Gelman Date: 3/5/2021...